'First-in-class' precision cancer drug shows promising results in Phase I trial
'First-in-class' precision cancer drug shows promising results in Phase I trial
A new drug targeting cancer’s ability to repair its DNA has shown promising results in a Phase I trial.
'First-in-class' precision cancer drug shows promising results in Phase I trial
!['First-in-class' precision cancer drug shows promising results in Phase I trial]()
Reviewed by Aditya
on
5:58 PM
Rating:
No comments: